Series C Biotechnology Companies

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

ANEUVO is a platform therapy development company focused on development of disruptive neuromodulation technologies.

ConcertAI is an AI-powered SaaS data company that develops medical research tools in oncology.

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.

Alivexis is a biotechnology company that engages in the research and development of custom medicine for the pharmaceutical industry.

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

ENOUGH is a food ingredient company that specializes in using the natural process of fermentation.

Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

Venture Med Group develops medical devices for vascular health, focusing on peripheral artery disease and arteriovenous access treatment.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Lumen Bio discovers, develops, and manufactures biologic drugs and vaccine candidates for various diseases.

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases